Avantor Gross Profit 2018-2025 | AVTR
Avantor annual/quarterly gross profit history and growth rate from 2018 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Avantor gross profit for the quarter ending September 30, 2025 was $0.527B, a 6.72% decline year-over-year.
- Avantor gross profit for the twelve months ending September 30, 2025 was $2.178B, a 4.74% decline year-over-year.
- Avantor annual gross profit for 2024 was $2.279B, a 3.57% decline from 2023.
- Avantor annual gross profit for 2023 was $2.364B, a 9.18% decline from 2022.
- Avantor annual gross profit for 2022 was $2.603B, a 4% increase from 2021.
|
Avantor Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $2,279 |
| 2023 | $2,364 |
| 2022 | $2,603 |
| 2021 | $2,503 |
| 2020 | $2,081 |
| 2019 | $1,921 |
| 2018 | $1,820 |
| 2017 | $433 |
|
Avantor Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $527 |
| 2025-06-30 | $554 |
| 2025-03-31 | $535 |
| 2024-12-31 | $563 |
| 2024-09-30 | $564 |
| 2024-06-30 | $582 |
| 2024-03-31 | $571 |
| 2023-12-31 | $570 |
| 2023-09-30 | $579 |
| 2023-06-30 | $590 |
| 2023-03-31 | $625 |
| 2022-12-31 | $615 |
| 2022-09-30 | $651 |
| 2022-06-30 | $648 |
| 2022-03-31 | $690 |
| 2021-12-31 | $648 |
| 2021-09-30 | $616 |
| 2021-06-30 | $627 |
| 2021-03-31 | $613 |
| 2020-12-31 | $582 |
| 2020-09-30 | $506 |
| 2020-06-30 | $491 |
| 2020-03-31 | $502 |
| 2019-12-31 | $480 |
| 2019-09-30 | $474 |
| 2019-06-30 | $491 |
| 2019-03-31 | $475 |
| 2018-12-31 | |
| 2018-09-30 | $479 |
| 2018-06-30 | $468 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.325B | $6.784B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $170.972B | 31.39 |
| HCA Healthcare (HCA) | United States | $106.211B | 17.58 |
| CVS Health (CVS) | United States | $103.446B | 11.90 |
| Elevance Health (ELV) | United States | $82.202B | 12.06 |
| Cencora (COR) | United States | $68.237B | 22.00 |
| Natera (NTRA) | United States | $33.582B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $22.312B | 17.01 |
| Medpace Holdings (MEDP) | United States | $17.481B | 43.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.574B | 0.00 |
| Viatris (VTRS) | United States | $15.031B | 5.60 |
| ICON (ICLR) | Ireland | $14.930B | 14.81 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.940B | 13.53 |
| Revvity (RVTY) | United States | $13.212B | 24.33 |
| CochLear (CHEOY) | Australia | $12.002B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.161B | 21.50 |
| Sonic Healthcare (SKHHY) | Australia | $7.861B | 0.00 |
| HealthEquity (HQY) | United States | $7.227B | 27.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.189B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.075B | 42.18 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 40.14 |
| PACS (PACS) | United States | $5.649B | 34.35 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.662B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.892B | 50.78 |
| Concentras Parent (CON) | United States | $2.818B | 17.59 |
| Organon (OGN) | United States | $2.493B | 2.63 |
| Progyny (PGNY) | United States | $2.194B | 43.14 |
| Surgery Partners (SGRY) | United States | $2.001B | 25.78 |
| Establishment Labs Holdings (ESTA) | United States | $1.967B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.895B | 11.32 |
| Ardent Health (ARDT) | United States | $1.223B | 3.99 |
| Teladoc Health (TDOC) | United States | $1.093B | 0.00 |
| CareDx (CDNA) | United States | $1.071B | 17.50 |
| Nutex Health (NUTX) | United States | $1.039B | 7.95 |
| Omada Health (OMDA) | United States | $0.905B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.876B | 14.33 |
| InnovAge Holding (INNV) | United States | $0.807B | 0.00 |
| Embecta (EMBC) | United States | $0.730B | 4.15 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| CryoPort (CYRX) | United States | $0.550B | 0.00 |
| Enhabit (EHAB) | United States | $0.544B | 24.41 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.488B | 0.00 |
| SBC Medicals (SBC) | United States | $0.451B | 8.30 |
| Agilon Health (AGL) | United States | $0.395B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.365B | 5.87 |
| Oncology Institute (TOI) | United States | $0.332B | 0.00 |
| So-Young (SY) | China | $0.310B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.302B | 63.60 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| KindlyMD (NAKA) | United States | $0.181B | 0.00 |
| LifeMD (LFMD) | United States | $0.170B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.087B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.076B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.34 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |